The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Heparin, a sulfated glycosaminoglycan, is well known for its anticoagulant effect mediated by the serine protease inhibitor antithrombin III (AT III). Heparin has been used clinically for more than half a century for the prophylaxis and treatment of venous thrombosis and thromboembolism. Up until the 1980s it was assumed that the biological activity of heparin was mainly caused by its polyanionic character. However, this paradigm was contradicted when it was discovered that part of the heparin polysaccharides contains a well‐defined pentasaccharide domain that specifically binds and activates AT III. The specificity of the interaction between the characteristic pentasaccharide and AT III has become more obvious after the synthesis and biological testing of various heparin analogues. This article reviews the synthesis of the heparin pentasaccharide, some closely related counterparts, and some highly modified analogues. With the aid of molecular modeling and through “tailored” molecular modifications of the pentasaccharide, much knowledge has been gained concerning structure‐activity relationships. On this basis not only have more potent and simplified derivatives been developed, but also the recognition between heparin and AT III can now be understood in greater detail at the molecular level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor
Rosenberg, R. D., & Damus, P. S. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43472-8 · Cited by 1,356
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes
Jackson, R. L., Busch, S. J., & Cardin, A. D. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.2.481 · Cited by 1,094
Huber, R., & Carrell, R. W. (1989) · Biochemistry · doi:10.1021/bi00449a001 · Cited by 883
High specificity of a phosphate transport protein determined by hydrogen bonds
Luecke, H., & Quiocho, F. A. (1990) · Nature · doi:10.1038/347402a0 · Cited by 537
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
Lindahl, U., Bäckström, G., Thunberg, L., & Leder, I. G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6551 · Cited by 498
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Olson, S. T., Björk, I., Sheffer, R., Craig, P. A., Shore, J. D., & Choay, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42309-5 · Cited by 470
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Sims, G. E. C. (1976) · Thrombosis Research · doi:10.1016/0049-3848(76)90105-5 · Cited by 457
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Structure and Biological Activity of Heparin
Casu, B. (1985) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(08)60067-0 · Cited by 428
Höök, M., Björk, I., Hopwood, J., & Lindahl, U. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80592-3 · Cited by 423
Casu, B., Oreste, P., Torri, G., Zoppetti, G., Choay, J., Lormeau, J. C., Petitou, M., & Sinaɕ, P. (1981) · Biochemical Journal · doi:10.1042/bj1970599 · Cited by 326
Self-citationStructure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
Maimone, M. M., & Tollefsen, D. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44747-8 · Cited by 297
Contribution of monosaccharide residues in heparin binding to antithrombin III
Atha, D. H., Lormeau, J. C., Petitou, M., Rosenberg, R. D., & Choay, J. (1985) · Biochemistry · doi:10.1021/bi00344a063 · Cited by 255
Self-citationMertens, G., Cassiman, J. J., Van den Berghe, H., Vermylen, J., & David, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88721-5 · Cited by 242
Conformer populations of l-iduronic acid residues in glycosaminoglycan sequences
Ferro, D. R., Provasoli, A., Ragazzi, M., Casu, B., Torri, G., Bossennec, V., Perly, B., Sinaÿ, P., Petitou, M., & Choay, J. (1990) · Carbohydrate Research · doi:10.1016/0008-6215(90)84164-p · Cited by 241
Self-citationFerro, D. R., Provasoli, A., Ragazzi, M., Torri, G., Casu, B., Gatti, G., Jacquinet, J. C., Sinay, P., Petitou, M., & Choay, J. (1986) · Journal of the American Chemical Society · doi:10.1021/ja00281a052 · Cited by 237
Self-citationTotal synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III
Sinaÿ, P., Jacquinet, J.-C., Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., & Torri, G. (1984) · Carbohydrate Research · doi:10.1016/0008-6215(84)85236-2 · Cited by 237
Self-citationOlson, S. T., Halvorson, H. R., & Björk, I. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38124-9 · Cited by 230
STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
Choay, J., Lormeau, J., Petitou, M., Sinay, P., & Fareed, J. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb29770.x · Cited by 224
Self-citationOlson, S. T., & Björk, I. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38125-0 · Cited by 220
The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group.
Lindahl, U., Bäckström, G., & Thunberg, L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44572-8 · Cited by 178
Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., Sînaÿ, P., Jacquinet, J., & Torri, G. (1986) · Carbohydrate Research · doi:10.1016/s0008-6215(00)90633-5 · Cited by 177
Self-citationPharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
Verstraete, M. (1990) · Drugs · doi:10.2165/00003495-199040040-00003 · Cited by 147
Atha, D. H., Lormeau, J. C., Petitou, M., Rosenberg, R. D., & Choay, J. (1987) · Biochemistry · doi:10.1021/bi00394a024 · Cited by 134
Self-citationHeparan sulphate in the binding and activation of basic fibroblast growth factor
Gallagher, J. T., & Turnbull, J. E. (1992) · Glycobiology · doi:10.1093/glycob/2.6.523 · Cited by 123
Torri, G., Casu, B., Gatti, G., Petitou, M., Choay, J., Jacquinet, J., & Sînaÿ, P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91655-9 · Cited by 114
Self-citationThe antithrombin-binding sequence of heparin. Location of essential N-sulfate groups.
Riesenfeld, J., Thunberg, L., Höök, M., & Lindahl, U. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69792-9 · Cited by 108
Transient Kinetics of Heparin-catalyzed Protease Inactivation by Antithrombin III
Craig, P., Olson, S. T., & Shore, J. D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83566-9 · Cited by 100
Anti-Xa active heparin oligosaccharides
Choay, J., Lormeau, J. C., Petitou, M., Sînaÿ, P., Casu, B., Oreste, P., Torri, G., & Gatti, G. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90356-4 · Cited by 90
Self-citationvan Boeckel, C. A. A., van Aelst, S. F., Wagenaars, G. N., Mellema, J. ‐., Paulsen, H. M., Peters, T., Pollex, A., & Sinnwell, V. (1987) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19871060102 · Cited by 79
Syntheses of heparin - like pentamers containing “opened” uronic acid moieties
Lucas, H., Hasten, J. E. M., van Dinther, T. G., Meuleman, D. G., van Aelst, S. F., & van Boeckel, C. A. A. (1990) · Tetrahedron · doi:10.1016/s0040-4020(01)81477-0 · Cited by 74
Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., & Sînaÿ, P. (1988) · Carbohydrate Research · doi:10.1016/0008-6215(88)84116-8 · Cited by 71
Self-citationInteraction of heparin and antithrombin III: The role of O‐sulfate groups
Petitou, M., Lormeau, J. C., & Choay, J. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14324.x · Cited by 67
Self-citationRodén, L., Ananth, S. L., Campbell, P., Curenton, T., Ekborg, G., Manzella, S. M., Pillion, D. J., & Meezan, E. (1992) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2444-5_1 · Cited by 50
Design and synthesis of a helix heparin-binding peptide
Ferran, D. S., Sobel, M., & Harris, R. B. (1992) · Biochemistry · doi:10.1021/bi00136a014 · Cited by 46
van Boeckel, C. A. A., Lucas, H., van Aelst, S. F., Nieuwenhof, M. W. P. K.-V. D., Wagenaars, G. N., & Mellema, J. ‐. (1987) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19871061107 · Cited by 22
Cited by
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
Bräse, S., Gil, C., Knepper, K., & Zimmermann, V. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200400657 · Cited by 2,497
Turpie, A. G. G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1833 · Cited by 736
The anticoagulant activation of antithrombin by heparin
Jin, L., Abrahams, J. P., Skinner, R., Petitou, M., Pike, R. N., & Carrell, R. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14683 · Cited by 685
Self-citationBauer, K. A., Eriksson, B. I., Lassen, M. R., & Turpie, A. G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011099 · Cited by 666
Eriksson, B. I., Bauer, K. A., Lassen, M. R., & Turpie, A. G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011100 · Cited by 631
Metadata
- Authors
- van Boeckel, C. A. A., & Petitou, M.
- Venue
- Angewandte Chemie International Edition in English
- Publisher
- Wiley
- Published
- 1993-12
- Volume
- 32
- Issue
- 12
- Pages
- 1671-1690
- ISSN
- 0570-0833 (ISSN-L)
- OpenAlex
- W2133048039
- Cited by
- 382
- References
- 37
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.